Zimbabwe's Securities Regulator Admits Seven Fintechs to Sandbox; Five Focus on Tokenization
Zimbabwe’s Securities Regulator Admits Seven Fintechs to Sandbox; Five Focus on Tokenization #
Zimbabwe’s Securities and Exchange Commission (SECZ) has admitted seven fintech companies to its regulatory sandbox. The approved list appeared in a public notice dated July 27, 2026, signed by acting CEO Tichaona Mushambadope.
Five of the seven participants are working on some form of asset tokenization. The cohort includes Zimbabwe Entrepreneurship Exchange, a blockchain-based capital-raising platform; Ndarama Standard, focused on asset tokenization; Questview Brokers, a synthetic trading platform; and Crowdaxe Capital, a web-based crowdfunding service. The remaining three, Procode Platforms, the Financial Securities Exchange (FINSEC), and Colmin Resources Zimbabwe, are each developing distinct forms of asset, infrastructure, or securities tokenization.
The regulator said the sandbox program aims to support responsible innovation, financial inclusion, and the development of a transparent and efficient capital market. Completing the program does not guarantee a commercial license; participants will still need to meet additional compliance requirements before receiving formal market authorization, according to Crypto Briefing.
SECZ said it will monitor and evaluate each participant throughout their testing periods and reserved the right to issue additional directives or operational requirements. The regulator also warned that claims made outside the approved testing parameters would be considered misleading, a measure aimed at protecting retail investors from premature product marketing.
The sandbox intake follows a separate move earlier this year by Zimbabwe’s Financial Intelligence Unit, which required all virtual asset service providers operating in the country to register with the central bank, imposed annual fees, and made unregistered operation a criminal offense. The SECZ program provides a supervised channel for early-stage firms to test products before applying for full authorization.